Document Detail

K+ channel blockade in the prevention of ventricular fibrillation in dogs with acute ischemia and enhanced sympathetic activity.
MedLine Citation:
PMID:  8606519     Owner:  NLM     Status:  MEDLINE    
The value of K+ channel blockade in preventing lethal arrhythmias, and specifically those triggered by acute myocardial ischemia and sympathetic hyperactivity, remains unproven. To address this issue, we tested the antifibrillatory effect of d-sotalol, and Ikr blocker, d,l-sotalol, its racemic compound which blocks Ikr, and beta-adrenoreceptors, and propranolol. Ten dogs with a healed anterior myocardial infarction (MI) had ventricular fibrillation (VF) during a 2-min occlusion of the circumflex coronary artery performed toward the end of a submaximal exercise stress test. In successive trials in the same animals, d-sotalol (three injections of 8 mg/kg, one every 12 h), d,l-sotalol (8 mg/kg), and propranolol (1 mg/kg) were tested. All three interventions significantly reduced heart rate (HR) response to exercise, but only d,l-sotalol and propranolol also blunted the reflex HR increase during acute myocardial ischemia. With d-sotalol, HR at 30 s of coronary occlusion was similar (253 +/- 28 beats/min) to that observed in the control tests (259 +/- 35 beats/min). d-Sotalol prevented recurrence of VF in only 1 of 10 dogs tested. One dog was lost to the continuation of the study after occurrence of VF with d-sotalol. Six of 9 dogs (67%) tested with d,l-sotalol and 5 (56%) of the same 9 dogs tested with propranolol were protected from VF. d-Sotalol does not reduce risk of VF during acute myocardial ischemia associated with sympathetic hyperactivity, and lethal events can be prevented by antiadrenergic interventions.
E Vanoli; S S Hull; P B Adamson; R D Foreman; P J Schwartz
Related Documents :
7391969 - A model to describe myocardial drug disposition in the dog.
2046029 - Effects of lidocaine on reperfusion arrhythmias and electrophysiological properties in ...
2908709 - Left ventricular function and beta-blockers: does intrinsic sympathomimetic activity ha...
7669959 - Hemodynamic effects of the novel selective camp-phosphodiesterase iii inhibitor r 80122...
7191789 - Myocardial electrical instability after abrupt withdrawal of long-term administration o...
3080299 - A seizure induced by concurrent lidocaine-tocainide therapy--is it just a case of addit...
14684169 - H2s generated by heart in rat and its effects on cardiac function.
10220629 - Elevated cardiac troponin i predicts a high-risk angiographic anatomy of the culprit le...
3553039 - Enhancement of metabolism of jeopardized myocardium by nifedipine.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  26     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  1995 Dec 
Date Detail:
Created Date:  1996-05-23     Completed Date:  1996-05-23     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  847-54     Citation Subset:  IM    
Istituto di Clinica Medica Generale e Terapia Medica, Università di Milano, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Arrhythmia Agents / pharmacology*
Blood Pressure / drug effects
Heart Rate / drug effects
Myocardial Ischemia / complications*,  physiopathology
Potassium Channel Blockers*
Propranolol / pharmacology
Sotalol / pharmacology*
Sympathetic Nervous System / drug effects*,  physiopathology
Ventricular Fibrillation / prevention & control*
Reg. No./Substance:
0/Anti-Arrhythmia Agents; 0/Potassium Channel Blockers; 3930-20-9/Sotalol; 525-66-6/Propranolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Fresh vein allograft survival in dogs after cyclosporine treatment.
Next Document:  Myocardial depression by isoflurane is dependent on the underlying beta-adrenergic tone.